Search Results - Garratt, Chris

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients

    Population Pharmacokinetics of Dexmedetomidine in Critically Ill Patients by Välitalo, Pyry Antti, Ahtola-Sätilä, Tuula, Wighton, Andrew, Sarapohja, Toni, Pohjanjousi, Pasi, Garratt, Chris

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    A multinational, drug utilization study to investigate the use of dexmedetomidine (Dexdor®) in clinical practice in the EU

    A multinational, drug utilization study to investigate the use of dexmedetomidine (Dexdor®) in clinical practice in the EU by Weatherall, Mary, Aantaa, Riku, Conti, Giorgio, Garratt, Chris, Pohjanjousi, Pasi, Lewis, Michael A., Moore, Nicholas, Perez‐Gutthann, Susana

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients

    Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients by Iirola, Timo, Aantaa, Riku, Laitio, Ruut, Kentala, Erkki, Lahtinen, Maria, Wighton, Andrew, Garratt, Chris, Ahtola-Sätilä, Tuula, Olkkola, Klaus T

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    Effects of dexmedetomidine and propofol on patient-ventilator interaction in difficult-to-wean, mechanically ventilated patients: a prospective, open-label, randomised, multicentre study

    Effects of dexmedetomidine and propofol on patient-ventilator interaction in difficult-to-wean, mechanically ventilated patients: a prospective, open-label, randomised, multicentre... by Conti, Giorgio, Ranieri, Vito Marco, Costa, Roberta, Garratt, Chris, Wighton, Andrew, Spinazzola, Giorgia, Urbino, Rosario, Mascia, Luciana, Ferrone, Giuliano, Pohjanjousi, Pasi, Ferreyra, Gabriela, Antonelli, Massimo

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours

    Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours by Bono, Petri, Massard, Christophe, Peltola, Katriina J, Azaro, Analía, Italiano, Antoine, Kristeleit, Rebecca S, Curigliano, Giuseppe, Lassen, Ulrik, Arkenau, Hendrik-Tobias, Hakulinen, Pasi, Garratt, Chris, Ikonen, Tarja, Mustonen, Mika V J, Rodon, Jordi A

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: